In:
Pediatric Dermatology, Wiley, Vol. 37, No. 6 ( 2020-11), p. 1210-1211
Abstract:
Netherton syndrome (NS) is an orphan disease characterized by congenital ichthyosis, hair abnormalities, and atopy, with limited treatment options. We achieved temporary improvement only during the initial 6 weeks of treatment with dupilumab, which differs from the sustained improvement observed in 2 other recently published cases. Although the clinical presentation of atopy and increased pre‐allergic cytokines in NS patients suggest that dupilumab may be beneficial, larger studies are required.
Type of Medium:
Online Resource
ISSN:
0736-8046
,
1525-1470
Language:
English
Publisher:
Wiley
Publication Date:
2020
detail.hit.zdb_id:
2020833-9